Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors

NEW HAVEN, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that the company has appointed Bruce L. Downey to its Board of Directors.

Read the full press releaseCompany website